Trial by Data: Expanding Clinical Data
Featuring: Joseph Kim of Eli Lilly and Dr. Sam Volchenboum
We welcome Joseph Kim to Trial by Data to new thinking about clinical trials and expanding data collection for healthcare.
Joseph Kim serves as a Senior Advisor in Clinical Development Innovation at Lilly, focusing on developing and implementing innovative patient engagement solutions. He has spent over 15 years in the Pharma industry utilizing a unique approach that integrates his experiences working for Sponsors such as Shire and Merck, CROs, and technology vendors. Joseph has a robust combination of experience that includes early and late phase clinical research, and a well known history of innovation in the clinical research industry.
You can follow him on Twitter at @JoPeKim.
You can listen to the full episode, and others, on iTunes and SoundCloud.
Listen here: Trial by Data, presented by Litmus Health.
Each week, we like to pull out some of the key themes from the conversation, and provide you with the references associated with each topic. We believe that when it comes to knowledge and conversation, more is more.
Here are the key topics from this week’s episode:
Optimizing data outside EMR’s for patient benefits. Although there is a lot of data being collected outside of trials, it’s naive to think we can just turn all this new data into valuable science. We’ll need well-curated and standardized data. In order to put it to use, we will need to have rules in how that data is contributed and collected, and make sure that data is collected in a way that is scientifically valid. Right now, standards for data are left up to the individual device makers. In the medical and scientific community, we know the value of these standards, but the tech community operates differently, so these two industries are coming together with different approaches and mindsets
A new end-to-end patient experience to transform clinical research. More people should be involved in research, and want to be. But there are barriers to participation that we need to address. One area is certainly in raising awareness and connecting people with that research in meaningful yet simple ways. The second is based on accessibility, which include the current limitations of time and geography.
We look to how the research can be broken up to be more convenient, whether conducted in the home, or in local clinics.
The de-centralized clinical trial. Assuming we can get the data reliably, and it’s auditable and valid, it doesn’t really matter how that data is procured. Right now clinical trials are tied inextricably to brick-and-mortar clinics, which is very limiting. We want to look at how the research can be broken up to be more convenient for participants, whether that is collecting data at home or locally or digitally.
How startups can best engage with leading academics and researchers. Too often startups really haven’t done well in understanding the entire ecosystem or engaging the various stakeholders. Most startups look to user growth as the key metric, but the audiences are inherently different for various patients. They need to focus deeply and care about specific conditions rather than broadly, but also be able to consider all these different and complex areas and stakeholders.
Trial by Data, presented by Litmus Health, is a podcast exploring the data-driven technologies and strategies shaping the future of clinical trials. We cover the most pressing issues and questions facing researchers and clinicians today, in an ever-changing landscape. Listen in as we interview leaders and innovators in the field who are at the forefront of developing and using these data-driven approaches.
